Business Wire

AZ-BLUE-YONDER

18.11.2021 15:02:07 CET | Business Wire | Press release

Share
Blue Yonder Empowers Retailers to Drive Personalized, Omni-Channel Commerce Experiences

Focused on empowering retailers to meet and exceed the rapidly evolving consumer expectations around fulfillment speed, convenience and accuracy, and to reduce the cost to fulfill, Blue Yonder has launched several microservices under the Luminate™ Commerce portfolio to help retailers meet the demands of consumers. These individually deployable, augmentative microservices offer a reimagined and personalized consumer experience by allowing retailers to ensure order and fulfillment accuracy.

E-commerce was rapidly growing prior to 2020; however, the COVID-19 pandemic pushed even more consumers online, contributing an additional $105 billion in U.S. online revenue in 2020 and accelerating e-commerce by two years , as reported in Digital Commerce 360 . In addition, nearly $1 in every $5 spent on retail purchases continue to come from digital orders , according an analysis of Commerce Department Q2 2021 data.

“The traditional monolithic solutions are very limiting to retailers and don’t give them the ability to add new features. Our microservices allow retailers to augmentatively add new capabilities without the need to rip and replace their existing solutions. This allows them to realize the value of the new capabilities quickly and meet business goals. As a result, many of our customers start with one microservice and after seeing benefits, they come back to us to implement additional services to help them meet customer demands while also keeping an eye on their bottom line,” said Eugene Amigud, corporate vice president, Product Management and Architecture, Blue Yonder.

Whether curbside pickup, buy online pickup in store (BOPIS), shipped from/to store, or same-day delivery/last-mile, retailers need omni-channel solutions to help them digitally transform to meet e-commerce growth. That’s why Blue Yonder has launched an end-to-end suite of highly scalable and individually deployable digital commerce microservices that include:

  • Commits : Retailers can provide accurate, aggressive, and cost-effective promised delivery dates, and flexible fulfillment options early in the buying process to increase conversion rates, as well as optimize fulfillment to save costs. It enables retailers to deliver the right product, at the right time, through the consumers’ channel of choice, with the speed and convenience that consumers expect.
  • Inventory Availability : Everyone needs to know where inventory is located and how it can be used. Retailers can present shoppers with enterprise-wide, real-time inventory availability data to incent them to buy. Retailers can show shoppers what’s available at their local store versus available for shipping and incent them to buy with urgency messaging (for example, one item left). Consumers can also easily reserve and then later buy products.
  • Order Fulfillment : Retailers can perform store micro-fulfillment activities, i.e., pick, pack and fulfill orders, with increased accuracy and improved productivity. Store associates can serve customers thru various methods such as curbside delivery, deliver at home, delivery in-store, or ship to home. Store associates and managers have complete visibility of all store micro-fulfillment activities with actionable dashboards.
  • Order Services and Customer Order Visibility (COV) – This high-performing, scalable API-based microservice orchestrates and manages the entire order-to-cash lifecycle. It provides a centralized view of orders, whether they are placed from a retailer’s website, a physical store, an online marketplace or a call center — and across brands and geographies. Customer Order Visibility (COV) is a real-time tracking and monitoring solution with an intuitive user experience that enables customer service, retail and other staff to search, view and modify real-time order details in one place, creating a single, up-to-date repository of order information. The COV uses an integrated user interface so businesses can search, view and modify order details in one place, with complete visibility into each order and its fulfillment details. Leveraging unsupervised learning algorithms, COV generates actionable insights on metrics that organizations can use to optimize the promising and fulfillment process.

Powered by machine learning analytics, these microservices can quickly detect anomalies with minimal or no manual configuration and draw attention to areas of potential need, including stock out predictions, sell through rates, the need for markdowns, and inventory accuracy.

“Our microservices enable retailers to leverage stores in their digital transformation journey while continuing to manage existing day-to-day operations. Retailers can now empower today’s shoppers to make smarter decisions, increasing customer satisfaction while streamlining store fulfillment operations and increasing productivity and revenue,” said Omar Akilah, corporate vice president – Commerce, Blue Yonder.

Additional Resources:

About Blue Yonder

Blue Yonder is the world leader in digital supply chain and omni-channel commerce fulfillment. Our intelligent, end-to-end platform enables retailers, manufacturers and logistics providers to seamlessly predict, pivot and fulfill customer demand. With Blue Yonder, you can make more automated, profitable business decisions that deliver greater growth and re-imagined customer experiences. Blue Yonder - Fulfill your Potential blueyonder.com

“Blue Yonder” is a trademark or registered trademark of Blue Yonder Group, Inc. Any trade, product or service name referenced in this document using the name “Blue Yonder” is a trademark and/or property of Blue Yonder Group, Inc. All other company and product names may be trademarks, registered trademarks or service marks of the companies with which they are associated.

Link:

ClickThru

Social Media:

https://www.facebook.com/blueyonderai

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Alphatax Makes Two Acquisitions to Strengthen Transfer Pricing Capabilities4.8.2026 10:00:00 CEST | Press release

Acquisitions Expand Transfer Pricing Offering and Support Long-Term Platform Strategy Alphatax, the global tax compliance software provider, has today announced the acquisitions of TP Accurate and Intra Pricing Solutions, expanding its transfer pricing capabilities and reinforcing its ambition to build the world's first tax operating system. The acquisitions strengthen Alphatax's transfer pricing portfolio with complementary capabilities across financial transactions and documentation. TP Accurate provides specialist software for intra-group financing arrangements, while Intra Pricing Solutions' flagship product, TPGenie, enables multinational organisations and advisors to produce transfer pricing documentation using intelligent automation and AI. Together, they expand Alphatax's ability to support the full transfer pricing lifecycle, helping customers manage compliance more efficiently while improving governance and reducing audit risk. They also represent another step towards Alphata

LabPMM® Launches Global KMT2A MRD Testing Service to Support Menin Inhibitor Development and Acute Leukemia Care4.8.2026 09:10:00 CEST | Press release

LabPMM®, an Invivoscribe® subsidiary, today announced the global availability of its new KMT2A measurable residual disease (MRD) testing service. The highly sensitive digital PCR service is available to healthcare providers, clinical researchers, and biopharmaceutical partners through LabPMM’s global laboratory network, with CAP/CLIA-accredited testing available in the U.S. The service addresses a growing need for accurate molecular monitoring in acute leukemias.1,2,3 KMT2A rearrangements (KMT2Ar) are oncogenic drivers in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).4 These rearrangements are present in about 80% of infant cases and 5-15% of childhood and adult leukemia cases.5 KMT2Ar leukemias are associated with chemotherapy resistance, high relapse rates, and poor clinical outcomes.5 The emergence of menin inhibitors is transforming the therapeutic landscape for patients with AML and ALL, particularly those with KMT2A-rearranged and NPM1-mutated disease.6 The

“HATSUNE MIKU LIGHTS TOKYO” Debuts on July 254.8.2026 09:00:00 CEST | Press release

Giant Hatsune Miku Returns to Light Up Tokyo’s Night! The Tokyo Metropolitan Government has been presenting year-round projection mapping displays on the Tokyo Metropolitan Government Building, using light and sound to showcase a wide range of artistic expressions as part of its efforts to create new nighttime tourism attractions in Tokyo. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260802298570/en/ © Crypton Future Media, INC. On Saturday, July 25, "HATSUNE MIKU LIGHTS TOKYO", featuring the globally beloved virtual singer Hatsune Miku, held its first screening. The work brings the world of the popular song “M@GICAL☆CURE! LOVE ♥ SHOT!” to life across the entire façade of the Tokyo Metropolitan Government Building. Since its launch in February 2024, “TOKYO Night & Light” has welcomed visitors from Japan and around the world, with total attendance surpassing 1.55 million. As one of Tokyo’s emerging landmark attractions, the

Mosaic Therapeutics appoints Dr Allison Jeynes as Chair of the Board4.8.2026 09:00:00 CEST | Press release

Accomplished life sciences leader with a proven track record of driving successful development of novel therapeutics, joins Mosaic to guide its next phase of growthAllison brings three decades of drug development, board and executive leadership experience to support Mosaic’s transition towards a clinical-stage company Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) an oncology therapeutics company developing novel, targeted drug combinations across a range of haematological and solid cancers, today announced the appointment of Dr Allison Jeynes as Chair of the Board to support its next phase of growth and advancement towards clinical development. Allison succeeds Dr Edward Hodgkin, who remains a Non-Executive Director of the Board. Allison is a UK-trained oncologist and highly-experienced life sciences leader, and brings over three decades of drug development and executive experience to Mosaic Therapeutics. As CEO of Avillion, a clinical development company, for the last 13 year

TOHKnet and Adtran conduct Japan’s first 50G PON trial on a live network4.8.2026 09:00:00 CEST | Press release

News summary: TOHKnet is exploring next-generation PON to meet enterprise demand while maintaining continuity across its regional fiber network Using Adtran technology, the trial validated 50G PON, XGS-PON and EPON operating together on a single fiber network Results show a practical path to evolve networks, enabling phased upgrades while maximizing fiber assets and avoiding service disruption Adtran today announced that TOHKnet has completed Japan’s first live network trial demonstrating the coexistence of 50G PON, XGS-PON and EPON on a single fiber. Conducted in Sendai using Adtran’s SDX 6400 Series OLT, the demo showed how the platform enables three generations of PON technology to operate together in a live service environment. The results highlight a realistic path for operators to introduce 50G PON capacity while maintaining continuity for existing services, maximizing the value of deployed fiber assets and reducing the complexity and disruption typically associated with network

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye